JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Effects of Smoking on Neurocognitive Outcomes in Patients with Carbon Monoxide Poisoning

  • 0Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea.
Journal of Clinical Medicine +

|

April 12, 2025

|

April 12, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

This study investigated the "smoker's paradox" in acute carbon monoxide (CO) poisoning, finding no evidence of neuroprotection from smoking. After controlling for confounding factors, smoking status did not significantly impact neurocognitive outcomes.

Area Of Science

  • Toxicology
  • Neuroscience
  • Epidemiology

Background

  • The
  • smoker's paradox
  • suggests smoking may protect against acute carbon monoxide (CO) poisoning.
  • Prior research is limited by confounding variables and selection bias.

Purpose Of The Study

  • To investigate the neuroprotective hypothesis of smoking in acute CO poisoning.
  • To minimize bias by comparing neurocognitive outcomes between smokers and non-smokers.
  • To control for confounding variables using Propensity Score Matching (PSM).

Main Methods

  • Retrospective study of 1150 patients with acute CO poisoning.
  • Propensity Score Matching (PSM) applied to balance covariates (age, GCS, comorbidities, HBO2 therapy).
  • Comparison of neurocognitive outcomes between matched smokers and non-smokers at 1 month post-exposure.

Main Results

  • Initial analysis showed smokers had fewer poor outcomes before PSM.
  • After 1:1 PSM with 15 covariates (317 pairs), baseline characteristics were balanced.
  • No significant difference in neurocognitive outcomes between matched smokers and non-smokers (9.8% vs. 7.9%, p=0.461).

Conclusions

  • The study does not support a neuroprotective effect of smoking in acute CO poisoning.
  • After adjusting for confounders via PSM, smoking status was not significantly associated with better neurocognitive outcomes.
  • Findings challenge the
  • smoker's paradox
  • in this specific clinical context.

Keywords:

Related Concept Videos

CNS Depressants: Alcohol and Nicotine 01:27

157

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies 01:27

2.5K

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

• Symptom Review: Chronic symptoms such as persistent cough, sputum production, shortness of breath (dyspnea), and episodes of exacerbation are...

COPD: Pathogenesis and Clinical Features 01:20

193

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists 01:30

85

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Chronic Obstructive Pulmonary Disease 01:22

1.1K

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Hypoxia 01:23

847

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...